{
    "Trade/Device Name(s)": [
        "BIO-VENTURE Rapid Multi-Drug Test Easy Cup for OTC Use",
        "BIO-VENTURE Rapid Multi-Drug Test Split Key Cup for OTC Use",
        "BIO-VENTURE Rapid Multi-Drug Test Easy Cup for Rx Use",
        "BIO-VENTURE Rapid Multi-Drug Test Split Key Cup for Rx Use"
    ],
    "Submitter Information": "SHANGHAI VENTURE BIO-TECH CO., LTD.",
    "510(k) Number": "K180879",
    "Predicate Device Reference 510(k) Number(s)": [
        "K173303"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKZ",
        "JXM",
        "NFT",
        "DIO",
        "NFY",
        "NFV",
        "DJC",
        "NGG",
        "DNK",
        "NGI",
        "LDJ",
        "NFW"
    ],
    "Summary Letter Date": "October 30, 2018",
    "Summary Letter Received Date": "November 5, 2018",
    "Submission Date": "December 14, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3870",
        "21 CFR 862.3640"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Benzodiazepine test system",
        "Cocaine and cocaine metabolite test system",
        "Methamphetamine test system",
        "Cannabinoid test system",
        "Morphine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "d-Amphetamine",
        "Oxazepam",
        "Benzoylecgonine",
        "d-Methamphetamine",
        "Morphine",
        "Delta-9-THC-COOH"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Easy Cup",
        "Split Key Cup"
    ],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Competitive binding immunoassay",
        "Antigen-antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Kit",
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for BIO-VENTURE Rapid Multi-Drug Test Easy Cup and Split Key Cup for OTC and Rx use for qualitative detection of multiple drugs of abuse in human urine",
    "Indications for Use Summary": "Qualitative, preliminary detection of amphetamine, oxazepam, benzoylecgonine, methamphetamine, morphine, and marijuana metabolite in human urine using a rapid lateral flow immunoassay; intended for over-the-counter and prescription use as initial drug screening",
    "fda_folder": "Toxicology"
}